In the News

1858 News Items found
MSK Postdoc Siting Gan
Siting Gan has the heart of a rebel. Although she focused on physics in high school in Beijing, China, where she grew up, and chose to major in physics in college, she knew that she “wanted to do research and discover things myself.” That determination to pursue her own questions led her to biology and, ultimately, to a unique situation at Sloan Kettering Institute (SKI).
MSK robotic Whipple patient Chris Scott and his wife, Kathy
When Chris Scott met with his urologist in January 2022, he thought they’d talk about an issue he was having with his prostate. But the conversation to...
Laboratory coats hanging from pegs
MSK Research Highlights, November 23, 2022
New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute finds tumor-associated macrophages that express a specific transcription factor might be targeted to improve immunotherapy; examines how different mutational processes impact individual cell genomes in cancer; sheds new light on cell senescence in cancer; and offers new models to aid the search for new treatments for mesothelioma.
MSK's Tobias Walther and Robert Farese, Jr.
Learn about renowned cellular lipid and energy metabolism researchers Robert Farese, Jr., and Tobias Walther who recently joined the Sloan Kettering Institute, running their lab jointly.
Joyce Tyson
In the Clinic
An international study led by MSK investigators has found that liquid biopsies may improve survival in people with lung cancer. These blood tests are easier for patients than more traditional tissue biopsies.
Postdocs Francisco “Pancho” Barriga and Kaloyan Tsanov in the lab
Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.
MSK thoracic surgeon and lung cancer specialist David Jones.
An inherited mutation that contributes to lung cancer spread could be a target for therapies.
Selwyn M. Vickers, M.D., FACS
The list acknowledges and celebrates healthcare leaders who envision a better future for all New Yorkers and constitute New York’s ever-expanding and constantly improving healthcare system.
MSK medical oncologist and genitourinary cancer specialist Emily Feld
Feature
Learn what bladder cancer symptoms can mean in men and women.
Nancy Schroeder and her husband Mark
In the Clinic
Results from a phase 2 clinical trial report a combination of two checkpoint inhibitor immunotherapy drugs given before melanoma surgery prevents this aggressive skin cancer from coming back. This new drug combination also has fewer side effects than other immunotherapy treatments.